tiprankstipranks
Trending News
More News >
Sonova Holding AG Unsponsored ADR (SONVY)
OTHER OTC:SONVY
Advertisement

Sonova Holding AG (SONVY) Price & Analysis

Compare
31 Followers

SONVY Stock Chart & Stats


Sonova Holding AG News

SONVY FAQ

What was Sonova Holding AG Unsponsored ADR’s price range in the past 12 months?
Sonova Holding AG Unsponsored ADR lowest stock price was $52.89 and its highest was $77.47 in the past 12 months.
    What is Sonova Holding AG Unsponsored ADR’s market cap?
    Sonova Holding AG Unsponsored ADR’s market cap is $15.87B.
      When is Sonova Holding AG Unsponsored ADR’s upcoming earnings report date?
      Sonova Holding AG Unsponsored ADR’s upcoming earnings report date is Nov 14, 2025 which is in 100 days.
        How were Sonova Holding AG Unsponsored ADR’s earnings last quarter?
        Sonova Holding AG Unsponsored ADR released its earnings results on May 09, 2025. The company reported $1.706 earnings per share for the quarter, beating the consensus estimate of $1.365 by $0.341.
          Is Sonova Holding AG Unsponsored ADR overvalued?
          According to Wall Street analysts Sonova Holding AG Unsponsored ADR’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Sonova Holding AG Unsponsored ADR pay dividends?
            Sonova Holding AG Unsponsored ADR pays a Annually dividend of $0.63 which represents an annual dividend yield of 1.15%. See more information on Sonova Holding AG Unsponsored ADR dividends here
              What is Sonova Holding AG Unsponsored ADR’s EPS estimate?
              Sonova Holding AG Unsponsored ADR’s EPS estimate is 1.12.
                How many shares outstanding does Sonova Holding AG Unsponsored ADR have?
                Sonova Holding AG Unsponsored ADR has 298,134,030 shares outstanding.
                  What happened to Sonova Holding AG Unsponsored ADR’s price movement after its last earnings report?
                  Sonova Holding AG Unsponsored ADR reported an EPS of $1.706 in its last earnings report, beating expectations of $1.365. Following the earnings report the stock price went up 3.164%.
                    Which hedge fund is a major shareholder of Sonova Holding AG Unsponsored ADR?
                    Currently, no hedge funds are holding shares in SONVY

                    Sonova Holding AG Stock Smart Score

                    Company Description

                    Sonova Holding AG Unsponsored ADR

                    Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The company offers wireless communication products; rechargeable hearing aids; wireless headsets, speech enhanced hearables, audiophile headphones, microphones, and wireless transmission systems; and audiological care services. It also provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; consumer hearing products under the Sennheiser brand; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton brands. The company sells its products through independent distributors; and provides hearing care services through a network of approximately 3,600 stores and clinics. It operates in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

                    Sonova Holding AG (SONVY) Earnings & Revenues

                    SONVY Company Deck

                    SONVY Earnings Call

                    Q4 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call presented a mixed view with strong product launch feedback and solid sales growth, particularly in cochlear implants, but faced profitability pressures and challenging market conditions, especially in the Audiological Care segment.Read More>
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Insulet
                    Koninklijke Philips
                    Smith & Nephew Snats
                    Steris
                    Zimmer Biomet Holdings

                    Ownership Overview

                    0.99%<0.01%98.99%
                    Insiders
                    <0.01% Other Institutional Investors
                    98.99% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis